News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Targeting inflammation could help treat drug-resistant bowel cancer
Some bowel cancers that are resistant to treatment could be re-sensitised using drugs that reduce inflammation, according to new research.
Call for hospitals to use high-tech scans to diagnose prostate cancers when they can still be cured
Modern, sophisticated scans should be used in hospitals to pick out men whose prostate cancers have only spread to a limited number of sites, so they can be offered the chance of cure, a new assessment concludes.
How our supporters are helping us take on ‘stealth’ cancers
Professor Raj Chopra, Head of Cancer Therapeutics, thanked ICR supporters and spoke about his hopes for the future for cancer treatment – made possible by their support.
Patients with HPV-positive throat cancer should keep taking chemotherapy
Patients with human papillomavirus (HPV)-positive throat cancer should carry on receiving chemotherapy rather than switching to a targeted cancer drug, new clinical trial results have shown.
Public-private sector collaboration the theme as Minister visits The London Cancer Hub
Business Minister Lord Henley has visited The London Cancer Hub to discuss new opportunities for life-sciences businesses to collaborate with world-leading scientists from The Institute of Cancer Research (ICR), London.
Professor Laurence Pearl awarded prestigious Novartis Medal and Prize
Professor Laurence Pearl, Head of the Division of Structural Biology, has been awarded the Novartis Medal and Prize by the Biochemical Society.
ICR thanks star fundraisers for their significant contributions to our research
Bowel cancer patient and fundraiser Tim Morgan and founder of The Chris Lucas Trust, Lynn Lucas, were thanked at the October meeting of the ICR's Discovery Club for their phenomenal fundraising efforts to support our research.
ICR responds to NICE decision on olaparib for women with advanced ovarian cancer
NICE has announced today, its decision not to recommend olaparib for women with advanced ovarian cancer who had previously responded to platinum chemotherapy for six months or longer.
Climb of Life fundraising total hits £1 million
In its 12th year raising money for The Institute of Cancer Research, London, the Climb of Life has reached the tremendous milestone of raising over £1 million.
ICR welcomes TfL consultation on Sutton tram extension
The Institute of Cancer Research, London, has welcomed the opening of a formal planning consultation on new proposals to take the tram to Sutton station as a stepping stone towards extending the tram to The London Cancer Hub site.
Goodbye to one of our most inspirational teachers
Our students have thanked Professor Keith Jones for his support and dedication to training the next generation of cancer researchers as he retires from The Institute of Cancer Research, London.
ESMO 2018: Immunotherapy effective as first-line treatment for advanced head and neck cancer
Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a major phase III clinical trial.
